OBJECTIVE: To assess potentially inappropriate prescribing (PIP) using Beers (2012 version) and STOPP (2008 version) criteria in polypharmacy, community-dwelling, older patients. METHODS: From the information collected in the invoicing data of the prescriptions and the electronic medical records, a sample was selected of 223 ≥ 65-year-old patients who were taking simultaneously 10 or more drugs per day. Beers and STOPP criteria were separately applied, and the results obtained with the two methods were compared. RESULTS: A total of 141 (63.2%) patients presented at least one Beers criterion. The two most frequently observed Beers criteria independent of diagnosis were the use of benzodiazepines and the use of non-COX-2-selective non-steroidal anti-inflammatory drugs. With regard to Beers criteria considering diagnosis, the most frequent were the use of anticholinergic drugs in patients with lower urinary tract symptoms or benign prostatic hyperplasia, and the use of benzodiazepines, antipsychotics, zolpidem or H2-antihistamines, in patients with dementia or cognitive impairment. A total of 165 (73.9%) patients had at least one PIP according to the STOPP criteria. Duplicate drug classes and long-term use of long-acting benzodiazepines were the two most frequent STOPP criteria. DISCUSSION: Our study identified a high frequency of PIP in polymedicated community-dwelling older patients. Simultaneous application of Beers and STOPP criteria represents a useful tool to improve prescribing in this population group. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.
OBJECTIVE: To assess potentially inappropriate prescribing (PIP) using Beers (2012 version) and STOPP (2008 version) criteria in polypharmacy, community-dwelling, older patients. METHODS: From the information collected in the invoicing data of the prescriptions and the electronic medical records, a sample was selected of 223 ≥ 65-year-old patients who were taking simultaneously 10 or more drugs per day. Beers and STOPP criteria were separately applied, and the results obtained with the two methods were compared. RESULTS: A total of 141 (63.2%) patients presented at least one Beers criterion. The two most frequently observed Beers criteria independent of diagnosis were the use of benzodiazepines and the use of non-COX-2-selective non-steroidal anti-inflammatory drugs. With regard to Beers criteria considering diagnosis, the most frequent were the use of anticholinergic drugs in patients with lower urinary tract symptoms or benign prostatic hyperplasia, and the use of benzodiazepines, antipsychotics, zolpidem or H2-antihistamines, in patients with dementia or cognitive impairment. A total of 165 (73.9%) patients had at least one PIP according to the STOPP criteria. Duplicate drug classes and long-term use of long-acting benzodiazepines were the two most frequent STOPP criteria. DISCUSSION: Our study identified a high frequency of PIP in polymedicated community-dwelling older patients. Simultaneous application of Beers and STOPP criteria represents a useful tool to improve prescribing in this population group. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.
Authors: Magali Gonzalez-Colaço Harmand; Ana María Aldea-Perona; Carlos Boada-Fernández Del Campo; Almudena Areosa-Sastre; Consuelo Rodríguez-Jiménez; Marcelino García Sánchez-Colomer; Eduardo Fernández Quintana; Mercedes Plasencia-Nuñez; Paula Masiero-Aparicio; Candelaria Grillo-Grillo; Andrés Orellana-Mobilli; Mar García Sáiz; Carmen Duarte Diéguez; Mercedes Hornillos Calvo; Juan Antonio Avellana Zaragoza; Nicolás Martínez Velilla; Domingo de Guzmán Pérez Hernández; Mario Ruiz González; Encarnación Blanco Reina; Carmen Asensio Ostos; Ana Peiró; Lourdes Cabrera García; Fuensanta Hortigüela Moro; Herlinda Pérez Alayón; Iriana Espárrago García; Javier Santana Quilez; Javier Alonso Ramírez; Carlos Fernández Oropesa; Mª José López Varona; Mª Teresa Acín Gerico; Emilio Sanz Alvarez; María Ángeles Martín de la Sierra; María José Peñalver; Teresa Falomir Gómez; Jesús Ruiz Salazar; Gabriela Elizondo Rivas; Edmundo Rey Rodríguez Journal: Eur J Clin Pharmacol Date: 2019-05-08 Impact factor: 2.953
Authors: Josep Pastor Cano; Ana Aranda García; Juan José Gascón Cánovas; José Francisco Sánchez Ruiz; Víctor José Rausell Rausell; Mariana Tobaruela Soto Journal: Aten Primaria Date: 2017-05-13 Impact factor: 1.137